Skip to main content

Table 1 Characteristics of the eligible studies

From: Sero-prevalence of human immunodeficiency virus–hepatitis B virus (HIV–HBV) co-infection among pregnant women attending antenatal care (ANC) in sub-Saharan Africa (SSA) and the associated risk factors: a systematic review and meta-analysis

First author, year Country Study design Sampling technique Sample HBV/HIV co-infection Diagnostic Method QS
Andersson et al. [14] South Africa Cross-section Purposive 3089 53 ELISA 8
Bafa et al. [27] Ethiopia Cross-section Random 222 4 RDT 9
Chasela et al. [32] Malawi Cross-section Entire 2048 103 ELISA 9
Desalegn et al. [28] Ethiopia Cross-section Entire 202 1 EIA 6
Dionne-Odom et al. [60] Cameroon Cross-section Consecutive 7069 205 RDT 9
Ezechi et al. [46] Nigeria Cross-section Purposive 2391 101 ELISA 9
Ilboudo et al. [39] Burkina Faso Cross-section Purposive 115 14 RDT 6
Mbaawuaga et al. [47] Nigeria Cross-section Purposive 507 5 RDT 7
Mpody et al. [61] DR Congo Cross-section Entire 1377 65 ELISA 8
Abwonga et al. [55] Cameroon Cross-section Entire 301 5 RDT 7
Adesina et al. [48] Nigeria Cross-section Entire 721 64 ELISA 7
Amsalu et al. [29] Ethiopia Cross-section Purposive 475 10 RDT 8
Andreotti et al. [33] Malawi Cross-section Entire 309 28 RDT 7
Bassey et al. [49] Nigeria Cross-section Purposive 500 36 ELISA 8
Bayo et al. [37] Uganda Cross-section Random 402 4 ELISA 7
Dabsu et al. [30] Ethiopia Cross-section Convenient 421 1 RDT 8
Fomulu et al. [56] Cameroon Cross-section Consecutive 959 7 ELISA 8
Frempong et al. [41] Ghana Cross-section Consecutive 248 22 EIA 8
Helegbe et al. [42] Ghana Cross-section Purposive 3127 1 VCIA 9
Ikeako et al. [50] Nigeria Retrospective Entire 1239 3 ELISA 9
Kfutwah et al. [57] Cameroon Cross-section Entire 650 28 RDT 8
Lar et al. [18] Nigeria Cross-section Entire 135 16 ELISA 8
MacLean et al. [45] Mali Cross-section Entire 3659 14 ELISA 8
Manyahi et al. [36] Tanzania Cross-section Consecutive 249 7 ELISA 8
Mutagoma et al. [34] Rwanda Cross-section Entire 13,121 20 ELISA 9
Noubiap et al. [58] Cameroon Cross-section Consecutive 325 5 RDT 7
Ntiamoah et al. [43] Ghana Cross-section Purposive 124 11 RDT 6
Ojiegbe et al. [51] Nigeria Cross-section Purposive 300 3 ELISA 6
Pirillo et al. [35] Rwanda Cross-section Entire 82 2 RDT 7
Pirillo et al. [35] Uganda Cross-section Entire 164 8 ELISA 7
Rouet et al. [44] Ivory cost Retrospective Entire 449 45 ELISA 8
Seremba et al. [38] Uganda Cross-section Purposive 612 9 AAS 7
Simpore et al. [40] Burkina Faso Cross-section Entire 336 24 AAS 7
Tanjong Re et al. [59] Cameroon Cross-section Purposive 406 6 AAS 8
Thumbiran et al. [54] South Africa Cross-section Entire 570 18 ELISA 6
Usanga et al. [52] Nigeria Cross-section Purposive 562 5 ELISA 8
Ya’aba et al. [53] Nigeria Cross-section Purposive 330 90 ELISA 7
Zenebe et al. [31] Ethiopia Cross-section Random 318 4 RDT 9
  1. VCIA vitros chemi luminescent immunoassay, AAS abbott ARCHITECT system, ELISA enzyme linked immuno assay, EIA enzyme immuno assay, RDT rapid diagnostic test, QS quality score